<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220920056000N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-11</date_registration>
      <primary_sponsor>Ghoum University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of effect of DHA drop in development progression of gross motor and head circumference in children between 6 month and one years old Has a head growth disorder referred to Hazrat Masoumeh Hospital in Qom in 2022-2023</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of effect of DHA drop in development progression of gross motor and head circumference in children between 6 month and one years old Has a head growth disorder referred to Hazrat Masoumeh Hospital in Qom in 2022-2023</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65996</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization pattern: block - randomization unit: individual - randomization tool: R software - in a two-way blind way, Blinding description: After obtaining a written consent, medicine is given for 6 months, one group is given only vitamin AD drops and the second group is given AD and DHA drops in the amount of 40 mg. The appearance of the drops is the same and neither the therapist nor the patient can distinguish the type of drops.</study_design>
      <phase>3</phase>
      <hc_freetext>developmental disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: children, both boys and girls (whose number will be equal in both groups) between the ages of 6 months and 1 year, who are referred to Hazrat Masoumeh Hospital in Qom due to developmental disorders and small head circumference. DHA is given to patients in the amount of 40 mg. Intervention 2: Control group: children, both boys and girls (whose number will be the same in both groups) between the ages of 6 months and 1 year, who are referred to Hazrat Masoumeh Hospital in Qom due to developmental disorders and small head circumference after obtaining A written consent is given for 6 months of medication and they only receive vitamin AD drops.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
A part of the data such as the information related to the main outcome or the like can be shared.

When:
The access period starts 6 months after the results are published

To whom:
Researchers working in academic institutions

Conditions:
For use in similar research projects

Where to obtain:
Elham farasat - Hazrat Masoumeh Hospital, Qom

How to obtain:
Request from the vice president of research

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohsen Mullamohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Qom- Imam Street after Zainuddin Square- Hazrat Masoumeh Hospital</address>
        <city>Qom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3719815539</zip>
        <telephone>+98 25 3162 5224</telephone>
        <email>farasat_med@yahoo.com</email>
        <affiliation>Ghoum University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Elham Farasat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam blv</address>
        <city>Qom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3719815539</zip>
        <telephone>+98 25 3162 5224</telephone>
        <email>farasat_med@yahoo.com</email>
        <affiliation>Ghoum University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children, both boys and girls, between the ages of 6 months and 1 year, who are referred to Hazrat Masoumeh Hospital in Qom with small head circumference according to their age and developmental disorder.</inclusion_criteria>
      <agemin>6 months</agemin>
      <agemax>1 year</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Allergy symptoms in children
Intolerance of drops and vomiting
Lack of interest of parents to continue studying
Premature babies
Cerebral Palsy
Metabolic disorder
Two or more twins
History of head trauma
History of brain infection</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G93.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disorder of brain, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: children, both boys and girls (whose number will be equal in both groups) between the ages of 6 months and 1 year, who are referred to Hazrat Masoumeh Hospital in Qom due to developmental disorders and small head circumference. DHA is given to patients in the amount of 40 mg</i_keyword>
      <i_keyword>Control group: children, both boys and girls (whose number will be the same in both groups) between the ages of 6 months and 1 year, who are referred to Hazrat Masoumeh Hospital in Qom due to developmental disorders and small head circumference after obtaining A written consent is given for 6 months of medication and they only receive vitamin AD drops</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Size around the head of children 6 months to one year. Timepoint: Once every 2 months until 6 months, i.e. 4 times (beginning of birth, 2 months, 4 months, and 6 months). Method of measurement: Measure and compare with graph.</prim_outcome>
      <prim_outcome>Development of gross movements of children from 6 months to one year. Timepoint: Once every 2 months until 6 months, i.e. 4 times (beginning of birth, 2 months, 4 months, and 6 months). Method of measurement: Evolution Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Ability to acquire movement skills. Timepoint: Once every 2 months until 6 months, i.e. 4 times (beginning of birth, 2 months, 4 months, and 6 months). Method of measurement: Evolution Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ghoum University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-08-29</approval_date>
        <contact_name>Ethics Committee of Qom University of Medical Sciences</contact_name>
        <contact_address>Pediatric Clinical Research Development Unit, Hazrat Masoumeh Educational and Therapeutic Center, Imam Khomeini Street after Shahid Zainuddin Square, Qom, Iran. Qom Ghoum Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
